世界のサルコペニア治療市場は2023年に30億7,000万米ドルとなり、予測期間の2024年から2032年にかけて複合年間成長率（CAGR）4.48％で成長した。
サルコペニアは、筋肉量、筋力、身体機能が徐々に低下する進行性疾患で、主に高齢者層に影響を及ぼします。治療アプローチは、筋肉萎縮の緩和を目的とした医療介入、栄養補助食品、薬理学的解決策、理学療法レジメンに及びます。高齢者人口の増加と加齢に伴う筋肉の変性に関する認識の高まりにより、効果的なサルコペニア治療の需要は今後数年間で高まると予想されます。
サルコペニア治療市場の拡大は、さまざまな要因が重なって推進されています。主な推進要因としては、世界の高齢者人口の着実な増加、筋骨格ヘルスケアの技術的進歩、医療費の増加などが挙げられます。特に、健康的な老化と標的療法による筋肉の健康維持に重点が置かれていることが、市場の成長を後押ししています。しかし、この分野は、診断率の低さ、治療費の高さ、サルコペニアの標準化された治療プロトコルの欠如などの課題にも直面しています。これらの障壁にもかかわらず、パーソナライズされた治療法、デジタル健康モニタリングソリューション、革新的な薬理学的治療法の開発には大きなチャンスがあり、継続的な市場成長への道筋を提供しています。
地理的に見ると、北アメリカは、その強力な医療インフラ、高齢者人口の多さ、医療投資の増加により、サルコペニア治療市場をリードしています。もう1つの主要プレーヤーであるヨーロッパは、高齢化社会の健康意識の高まりの恩恵を受けています。一方、アジア太平洋地域は、急速に高齢化する人口、医療システムの改善、日本、中国、韓国などの国の積極的な政府イニシアチブにより、最も急速な成長が見込まれています。この地域の高度な治療法と健康ソリューションに対する需要の高まりは、将来の主要市場としての可能性を強調しています。
目次
Table of Contents
Chapter 1. Global Sarcopenia Treatment Market Executive Summary
1.1. Global Sarcopenia Treatment Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Treatment
1.3.2. By Route of Administration
1.3.3. By Distribution Channel
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Sarcopenia Treatment Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory Frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Sarcopenia Treatment Market Dynamics
3.1. Market Drivers
3.1.1. Growing Elderly Population
3.1.2. Advancements in Healthcare Technologies
3.1.3. Increasing Healthcare Expenditures
3.2. Market Challenges
3.2.1. High Treatment Costs
3.2.2. Limited Diagnosis Rates
3.3. Market Opportunities
3.3.1. Development of Personalized Therapies
3.3.2. Digital Health Platforms Integration
3.3.3. Innovative Treatment Solutions
Chapter 4. Global Sarcopenia Treatment Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economic
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunities
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Sarcopenia Treatment Market Size & Forecasts by Treatment 2022-2032
5.1. Segment Dashboard
5.2. Global Sarcopenia Treatment Market: Treatment Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Protein Supplements
5.2.2. Vitamin B12 Supplements
5.2.3. Vitamin D & Calcium Supplements
5.2.4. Others
Chapter 6. Global Sarcopenia Treatment Market Size & Forecasts by Route of Administration 2022-2032
6.1. Segment Dashboard
6.2. Global Sarcopenia Treatment Market: Route of Administration Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Oral
6.2.2. Parenteral
6.2.3. Enteral
Chapter 7. Global Sarcopenia Treatment Market Size & Forecasts by Distribution Channel 2022-2032
7.1. Segment Dashboard
7.2. Global Sarcopenia Treatment Market: Distribution Channel Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Hospital Pharmacies
7.2.2. Drug Stores & Retail Pharmacies
7.2.3. Online Pharmacies
Chapter 8. Global Sarcopenia Treatment Market Size & Forecasts by Region 2022-2032
8.1. North America Sarcopenia Treatment Market
8.1.1. U.S. Sarcopenia Treatment Market
8.1.1.1. Treatment Breakdown Size & Forecasts, 2022-2032
8.1.1.2. Route of Administration Breakdown Size & Forecasts, 2022-2032
8.1.2. Canada Sarcopenia Treatment Market
8.2. Europe Sarcopenia Treatment Market
8.2.1. U.K. Sarcopenia Treatment Market
8.2.2. Germany Sarcopenia Treatment Market
8.2.3. France Sarcopenia Treatment Market
8.2.4. Spain Sarcopenia Treatment Market
8.2.5. Italy Sarcopenia Treatment Market
8.2.6. Rest of Europe Sarcopenia Treatment Market
8.3. Asia Pacific Sarcopenia Treatment Market
8.3.1. China Sarcopenia Treatment Market
8.3.2. India Sarcopenia Treatment Market
8.3.3. Japan Sarcopenia Treatment Market
8.3.4. Australia Sarcopenia Treatment Market
8.3.5. South Korea Sarcopenia Treatment Market
8.3.6. Rest of Asia Pacific Sarcopenia Treatment Market
8.4. Latin America Sarcopenia Treatment Market
8.4.1. Brazil Sarcopenia Treatment Market
8.4.2. Mexico Sarcopenia Treatment Market
8.4.3. Rest of Latin America Sarcopenia Treatment Market
8.5. Middle East & Africa Sarcopenia Treatment Market
8.5.1. Saudi Arabia Sarcopenia Treatment Market
8.5.2. South Africa Sarcopenia Treatment Market
8.5.3. Rest of Middle East & Africa Sarcopenia Treatment Market
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Nestle Health Science
9.1.2. Sanofi S.A.
9.1.3. Bayer AG
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Nestle Health Science
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Market Strategies
9.3.2. Sanofi S.A.
9.3.3. Bayer AG
9.3.4. Haleon Group of Companies
9.3.5. Novartis AG
9.3.6. Abbott Laboratories
9.3.7. Metagenics LLC
9.3.8. Pfizer, Inc.
9.3.9. GlaxoSmithKline plc.
9.3.10. Makers Nutrition LLC
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
List of Tables
TABLE 1. Global Sarcopenia Treatment Market, Report Scope
TABLE 2. Global Sarcopenia Treatment Market Estimates & Forecasts by Region 2022-2032 (USD Billion)
TABLE 3. Global Sarcopenia Treatment Market Estimates & Forecasts by Treatment 2022-2032 (USD Billion)
TABLE 4. Global Sarcopenia Treatment Market Estimates & Forecasts by Route of Administration 2022-2032 (USD Billion)
TABLE 5. Global Sarcopenia Treatment Market Estimates & Forecasts by Distribution Channel 2022-2032 (USD Billion)
TABLE 6. U.S. Sarcopenia Treatment Market Estimates & Forecasts by Treatment 2022-2032 (USD Billion)
TABLE 7. U.S. Sarcopenia Treatment Market Estimates & Forecasts by Route of Administration 2022-2032 (USD Billion)
TABLE 8. U.S. Sarcopenia Treatment Market Estimates & Forecasts by Distribution Channel 2022-2032 (USD Billion)
TABLE 9. Canada Sarcopenia Treatment Market Estimates & Forecasts by Treatment 2022-2032 (USD Billion)
TABLE 10. Europe Sarcopenia Treatment Market Estimates & Forecasts by Treatment 2022-2032 (USD Billion)
…..
This list is not complete, final report does contain more than 100 tables. The list may be updated in the final deliverable
List of Figures
FIG 1. Global Sarcopenia Treatment Market, Research Methodology
FIG 2. Global Sarcopenia Treatment Market, Market Estimation Techniques
FIG 3. Global Sarcopenia Treatment Market Size Estimates & Forecast Methods
FIG 4. Global Sarcopenia Treatment Market, Key Trends 2023
FIG 5. Global Sarcopenia Treatment Market, Growth Prospects 2022-2032
FIG 6. Global Sarcopenia Treatment Market, Porter's 5 Force Model
FIG 7. Global Sarcopenia Treatment Market, PESTEL Analysis
FIG 8. Global Sarcopenia Treatment Market, Value Chain Analysis
FIG 9. U.S. Sarcopenia Treatment Market by Treatment, 2022 & 2032 (USD Billion)
FIG 10. U.S. Sarcopenia Treatment Market by Route of Administration, 2022 & 2032 (USD Billion)
FIG 11. Europe Sarcopenia Treatment Market by Treatment, 2022 & 2032 (USD Billion)
FIG 12. Asia-Pacific Sarcopenia Treatment Market by Treatment, 2022 & 2032 (USD Billion)
…..
This list is not complete, final report does contain more than 50 figures. The list may be updated in the final deliverable.
